Jean-Christophe Hoflack

Company: F Hoffmann-La Roche

Job title: Senior Principal Scientist

Seminars:

Oligonucleotide Therapeutics: Case Studies, Current Industry Recommendations, & Future Perspectives 4:00 pm

Detection and risk assessment of hybridization-mediated off-targets Current strategic recommendations from an industrial perspective Pending challenges and the need for enhanced specificity and selectivity’Read more

day: Conference Day One